Editorial Comment to Treatment outcomes of sorafenib for first line or cytokine-refractory advanced renal cell carcinoma in Japanese patients

✍ Scribed by Yoshihiko Tomita

• Book ID: 108980240
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 95 KB
• Volume: 17
• Category: Article
• ISSN: 0919-8172
• DOI: 10.1111/j.1442-2042.2010.02625.x